HY-13683-100mg
|
MedChemexpress LLC
|
Mifepristone [CAS 84371-65-3]
|
|
Cancer-programmed cell death
|
|
HY-13683-50mg
|
MedChemexpress LLC
|
Mifepristone [CAS 84371-65-3]
|
|
Cancer-programmed cell death
|
|
HY-13683-500mg
|
MedChemexpress LLC
|
Mifepristone [CAS 84371-65-3]
|
|
Cancer-programmed cell death
|
|
HY-13683-1mL
|
MedChemexpress LLC
|
Mifepristone [CAS 84371-65-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-13683S-1mg
|
MedChemexpress LLC
|
Mifepristone-d3
|
|
|
|
HY-10244-10mg
|
MedChemexpress LLC
|
MK-0608 [CAS 443642-29-3]
|
|
COVID-19-anti-virus
|
|
HY-10244-5mg
|
MedChemexpress LLC
|
MK-0608 [CAS 443642-29-3]
|
|
COVID-19-anti-virus
|
|
HY-10244-50mg
|
MedChemexpress LLC
|
MK-0608 [CAS 443642-29-3]
|
|
COVID-19-anti-virus
|
|
HY-10244-1mL
|
MedChemexpress LLC
|
MK-0608 [CAS 443642-29-3] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
HY-14442-5mg
|
MedChemexpress LLC
|
ML 10302 (hydrochloride) [CAS 186826-17-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-12805-100mg
|
MedChemexpress LLC
|
ML171 [CAS 6631-94-3]
|
|
COVID-19-immunoregulation
|
|
HY-12805-500mg
|
MedChemexpress LLC
|
ML171 [CAS 6631-94-3]
|
|
COVID-19-immunoregulation
|
|
HY-12805-1mL
|
MedChemexpress LLC
|
ML171 [CAS 6631-94-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-103254-10mg
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-103254-100mg
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-103254-25mg
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-103254-5mg
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-103254-50mg
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-103254-1mL
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
HY-116814-1mg
|
MedChemexpress LLC
|
ML401 [CAS 1597489-14-9]
|
|
Neuroscience-Neuromodulation
|
|
HY-116814-10mg
|
MedChemexpress LLC
|
ML401 [CAS 1597489-14-9]
|
|
Neuroscience-Neuromodulation
|
|
HY-116814-100mg
|
MedChemexpress LLC
|
ML401 [CAS 1597489-14-9]
|
|
Neuroscience-Neuromodulation
|
|
HY-116814-25mg
|
MedChemexpress LLC
|
ML401 [CAS 1597489-14-9]
|
|
Neuroscience-Neuromodulation
|
|
HY-116814-5mg
|
MedChemexpress LLC
|
ML401 [CAS 1597489-14-9]
|
|
Neuroscience-Neuromodulation
|
|
HY-116814-50mg
|
MedChemexpress LLC
|
ML401 [CAS 1597489-14-9]
|
|
Neuroscience-Neuromodulation
|
|